×
About 3,380 results

ALLMedicine™ Apolipoprotein B Center

Research & Reviews  1,084 results

Association between apolipoprotein B/A1 ratio and coronary plaque vulnerability in pati...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442358
Cardiovascular Diabetology; Deng F, Li D et. al.

Sep 17th, 2021 - Apolipoprotein (Apo) A1 and Apo B are strongly associated with the risk of atherosclerotic cardiovascular disease (ASCVD). However, the relationship between the Apo B/A1 ratio and the morphology of coronary vulnerable plaques has not been fully el...

Nutrient Patterns are Associated with Discordant Apolipoprotein B and Low-Density Lipop...
https://doi.org/10.1017/S000711452100369X
The British Journal of Nutrition; Mazidi M, Webb RJ et. al.

Sep 16th, 2021 - Individuals with discordantly high ApoB to LDL-C levels carry a higher risk of atherosclerotic cardiovascular disease compared to those with average or discordantly low ApoB to LDL-C. We aimed to determine associations between ApoB and LDL-C disco...

Sterol and lipid analyses identifies hypolipidemia and apolipoprotein disorders in auti...
https://doi.org/10.1038/s41398-021-01580-8 10.1176/appi.books.9780890425596 10.1016/0006-8993(69)90209-1 10.1203/00006450-199204000-00018 10.1074/jbc.M405345200 10.1038/ncb2210 10.3389/fpsyt.2016.00176 10.1007/s10048-008-0133-5 10.1002/aur.33 10.1194/jlr.P033449 10.1172/JCI105580 10.1016/j.euroneuro.2004.12.004 10.1080/09540260801889062 10.1002/aur.1777 10.3389/fphys.2017.00841 10.1172/JCI112130 10.1097/00041433-200104000-00003 10.1093/cvr/cvu148 10.1073/pnas.76.9.4646 10.1007/s13238-014-0131-3 10.1002/mds.22013 10.1523/JNEUROSCI.3355-05.2005 10.1038/nrneurol.2011.132 10.1212/01.wnl.0000333215.93440.36 10.18632/aging.103983 10.1093/hmg/ddy384 10.1016/j.jneuroim.2014.10.010 10.1016/0009-8981(95)06115-T 10.1097/MOL.0000000000000604 10.1002/mus.20821 10.1038/srep30391 10.1073/pnas.74.9.4025 10.1002/ana.20593 10.1073/pnas.90.5.1977 10.1023/A:1013290826504 10.1016/j.conb.2009.06.003 10.1073/pnas.0910872107 10.5483/BMBRep.2019.52.7.137 10.1002/ajmg.a.36850 10.1371/journal.pone.0174301 10.1007/s11745-015-4109-6 10.1038/ng.2738 10.1016/j.freeradbiomed.2015.05.010 10.1016/0140-6736(93)90983-N 10.1073/pnas.95.14.8181 10.1086/301936 10.1086/301982 10.1016/0009-8981(95)06038-4 10.1186/s11689-016-9145-x 10.1136/jmg.37.5.321 10.1002/ajmg.a.35376 10.1002/1096-8628(20010115)98:2<191::AID-AJMG1030>3.0.CO;2-M 10.1002/ajmg.a.31294 10.1023/A:1005668305864 10.1007/s00431-012-1925-z 10.1002/ajmg.b.30368 10.1002/aur.2183 10.1016/j.nutres.2010.04.002 10.1038/sj.mp.4001943 10.1016/j.rasd.2020.101630 10.1186/2040-2392-5-4 10.1371/journal.pone.0157937 10.1016/j.psychres.2006.02.003 10.1038/s41591-020-1007-0 10.1086/321292 10.1006/pmed.1998.0376 10.1161/CIRCULATIONAHA.106.620864 10.1093/clinchem/43.12.2364 10.1016/S1058-9813(03)00054-7 10.1161/CIRCULATIONAHA.108.816769 10.1097/DBP.0b013e3182a00d17 10.1016/j.ymgme.2013.04.004 10.1021/acs.chemrestox.6b00054 10.1007/8904_2013_255 10.3109/00365518909105417 10.1093/oxfordjournals.aje.a115479 10.1161/01.ATV.0000176191.64314.07 10.1056/NEJMoa1612790 10.1056/NEJMoa1002926 10.1194/jlr.P039875 10.1016/j.tcm.2007.10.003 10.3389/fendo.2014.00004 10.1038/nrendo.2017.119 10.1146/annurev-nutr-071811-150703 10.1369/0022155413505601 10.3390/ijms21218338 10.15252/msb.20145487 10.1007/s00018-012-0977-6 10.1016/j.numecd.2012.11.008 10.1161/ATVBAHA.109.196550
Translational Psychiatry; Tierney E, Remaley AT et. al.

Sep 11th, 2021 - An improved understanding of sterol and lipid abnormalities in individuals with autism spectrum disorder (ASD) could lead to personalized treatment approaches. Toward this end, in blood, we identified reduced synthesis of cholesterol in families w...

Exploring potential serum levels of Homocysteine, interleukin-1 beta, and apolipoprotei...
https://doi.org/10.1002/jcla.23996
Journal of Clinical Laboratory Analysis; Shademan B, Nourazarian A et. al.

Sep 8th, 2021 - Stroke is the second leading cause of death worldwide with heterogeneous characteristics. The subtypes of stroke are due to different pathophysiological regulations and causes. This study aimed to investigate the correlation of serum levels of apo...

Hepatitis C virus induces oxidation and degradation of apolipoprotein B to enhance lipi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448335
PLoS Pathogens; Wang B, Zhu Y et. al.

Sep 8th, 2021 - Hepatitis C virus (HCV) infection induces the degradation and decreases the secretion of apolipoprotein B (ApoB). Impaired production and secretion of ApoB-containing lipoprotein is associated with an increase in hepatic steatosis. Therefore, HCV ...

see more →

Guidelines  3 results

Menopause symptom management in women with dyslipidemias: An EMAS clinical guide.
https://doi.org/10.1016/j.maturitas.2020.03.007
Maturitas Anagnostis P, Bitzer J et. al.

Mar 27th, 2020 - Dyslipidemias are common and increase the risk of cardiovascular disease. The menopause transition is associated with an atherogenic lipid profile, with an increase in the concentrations of total cholesterol (TC) and low-density lipoprotein choles...

Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL...
https://doi.org/10.1373/clinchem.2012.196733
Clinical Chemistry; , Cole TG et. al.

Feb 7th, 2013 - The number of circulating LDL particles is a strong indicator of future cardiovascular disease (CVD) events, even superior to the concentration of LDL cholesterol. Atherogenic (primarily LDL) particle number is typically determined either directly...

Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipo...
https://doi.org/10.1373/clinchem.2008.118356
Clinical Chemistry; Contois JH, McConnell JP et. al.

Jan 27th, 2009 - Low-density lipoprotein cholesterol (LDL-C) has been the cornerstone measurement for assessing cardiovascular risk for nearly 20 years. Recent data demonstrate that apolipoprotein B (apo B) is a better measure of circulating LDL particle number (L...

see more →

Drugs  185 results see all →

News  80 results

LDL Not the Primary Culprit in ASCVD?
https://www.medscape.com/viewarticle/942629

Dec 14th, 2020 - Two new studies suggest that low-density lipoprotein cholesterol (LDL-C) may be not the main driver of atherosclerotic cardiovascular disease (ASCVD). The findings instead implicate remnant cholesterol (remnant-C) and very low-density lipoprotein ...

STRENGTH Trial Questions CV Benefit of High-Dose Omega-3s
https://www.medscape.com/viewarticle/941018

Nov 15th, 2020 - Questions about the cardiovascular benefit of omega-3 fatty acids and the high-dose eicosapentaenoic acid (EPA) product, icosapent ethyl (Vascepa, Amarin), have resurfaced with the presentation and publication of the STRENGTH trial using a combine...

Lipid Ratio Rules Out Pancreatitis Risk in Hypertriglyceridemia
https://www.medscape.com/viewarticle/939205

Oct 15th, 2020 - Calculating the ratio between serum triglyceride and apolipoprotein B levels may help rule out patients with hypertriglyceridemia who are at low risk of developing hypertriglyceridemic pancreatitis (HTGP), and so better guide management, suggests ...

Lipid Ratio Rules Out Pancreatitis Risk in Hypertriglyceridemia
https://www.staging.medscape.com/viewarticle/939205

Oct 15th, 2020 - Calculating the ratio between serum triglyceride and apolipoprotein B levels may help rule out patients with hypertriglyceridemia who are at low risk of developing hypertriglyceridemic pancreatitis (HTGP), and so better guide management, suggests ...

Depression or Anxiety? Metabolic Blood Biomarkers May Tell the Tale
https://www.medscape.com/viewarticle/938079

Sep 25th, 2020 - Metabolic alterations linked to inflammation and lipid metabolism can distinguish depression from anxiety and determine disease severity, new research suggests.  Results from a Dutch study included 1400 participants with anxiety, depression, or bo...

see more →